Sarepta Therapeutics (SRPT) Short-term Investments (2013 - 2026)
Sarepta Therapeutics' quarterly Short-term Investments came in at $188.7 million in Q1 2026, down 33.05% year-on-year from $281.9 million in Q1 2025, and up 36.4% quarter-over-quarter from $138.4 million in Q4 2025.
Sarepta Therapeutics has reported Short-term Investments for 14 years, with the latest figure at $188.7 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments fell 33.05% year-over-year to $188.7 million; the trailing twelve-month figure through Mar 2026 stood at $188.7 million (down 33.05% YoY), and the FY2025 full-year result was $138.4 million, down 45.04% from the prior year.
- Short-term Investments for Q1 2026 stood at $188.7 million, up from $138.4 million in the prior quarter.
- The five-year high for Short-term Investments was $1.2 billion in Q4 2023, with the low at $138.4 million in Q4 2025.
- Average Short-term Investments over 5 years is $752.0 million, with a median of $1.0 billion recorded in 2024.
- Year-over-year, Short-term Investments surged 3431.51% in 2022 and tumbled 79.82% in 2024.
- Tracing SRPT's Short-term Investments over 5 years: stood at $1.0 billion in 2022, then gained by 22.02% to $1.2 billion in 2023, then plunged by 79.82% to $251.8 million in 2024, then plunged by 45.04% to $138.4 million in 2025, then soared by 36.4% to $188.7 million in 2026.
- The last three Short-term Investments figures came in at $188.7 million (Q1 2026), $138.4 million (Q4 2025), and $237.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188.74 Mn |
| Dec 31, 2025 | 138.37 Mn |
| Sep 30, 2025 | 237.92 Mn |
| Jun 30, 2025 | 289.54 Mn |
| Mar 31, 2025 | 281.90 Mn |
| Dec 31, 2024 | 251.78 Mn |
| Sep 30, 2024 | 1.00 Bn |
| Jun 30, 2024 | 1.08 Bn |
| Mar 31, 2024 | 963.50 Mn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.01 Bn |
| Mar 31, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.02 Bn |
| Sep 30, 2022 | 1.03 Bn |
| Jun 30, 2022 | 1.06 Bn |
| Mar 31, 2022 | 779.50 Mn |
| Jun 30, 2021 | 30.00 Mn |
| Mar 31, 2021 | 256.00 Mn |
| Dec 31, 2020 | 435.92 Mn |
| Sep 30, 2020 | 341.47 Mn |
| Jun 30, 2020 | 421.35 Mn |
| Mar 31, 2020 | 406.94 Mn |
| Dec 31, 2019 | 289.67 Mn |
| Sep 30, 2019 | 324.10 Mn |
| Jun 30, 2019 | 294.48 Mn |
| Mar 31, 2019 | 612.02 Mn |
| Dec 31, 2018 | 803.08 Mn |
| Sep 30, 2018 | 583.16 Mn |
| Jun 30, 2018 | 538.77 Mn |
| Mar 31, 2018 | 491.76 Mn |
| Dec 31, 2017 | 479.37 Mn |
| Jun 30, 2017 | 132.60 Mn |
| Mar 31, 2017 | 115.59 Mn |
| Dec 31, 2016 | 195.43 Mn |
| Sep 30, 2016 | 16.78 Mn |
| Jun 30, 2016 | 11.40 Mn |
| Mar 31, 2016 | 12.93 Mn |
| Dec 31, 2015 | 10.70 Mn |
| Sep 30, 2015 | 44.09 Mn |
| Jun 30, 2015 | 19.55 Mn |
| Mar 31, 2015 | 20.66 Mn |
| Dec 31, 2014 | 136.79 Mn |
| Sep 30, 2014 | 4.00 Mn |
| Jun 30, 2014 | 4.00 Mn |
| Mar 31, 2014 | 176.09 Mn |
| Dec 31, 2013 | 7.25 Mn |
| Sep 30, 2013 | 7.25 Mn |
| Jun 30, 2013 | 7.25 Mn |